ReviewPharmaceuticals (Basel, Switzerland)2026
Phosphatidylinositol-3-Kinase (PI3K) and Histone Deacetylase (HDAC) Multitarget Inhibitors: An Update on Clinical and Preclinical Candidates.
Alef D S Lima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.